Tympanoplasty is an otologic surgical intervention within the specialty of otolaryngology (ear, nose, and throat surgery). The primary objective of the procedure is to close a persistent defect in the tympanic membrane (eardrum) and, when necessary, reconstruct the ossicular chain—the tiny middle ear bones comprising the malleus (hammer), incus (anvil), and stapes (stirrup). By restoring the mechanical vibrating barrier of the ear, the surgery seeks to stop chronic ear drainage (otorrhea), protect the middle ear space from environmental pathogens, and eliminate conductive hearing loss by restoring efficient sound transfer to the inner ear.

Step 1: Patient administration of general or monitored local anesthesia followed by antiseptic preparation of the pinna and canal. Step 2: Harvest of autologous graft tissue, typically temporalis fascia or tragal cartilage/perichondrium, which is thinned, shaped, and dehydrated on a surgical press. Step 3: Operative field visual acquisition via an operating microscope or wide-angle ear endoscope. Step 4: Paring and de-epithelialization of the perforation margins using micro-hooks to create a fresh, vascularized tissue bed. Step 5: Creation of a tympanomeatal flap by making incision lines in the external ear canal skin, elevating the skin and posterior remnant eardrum forward. Step 6: Exploration and mobilization assessment of the ossicular chain (malleus, incus, stapes). Step 7: Placement of absorbable gelatin sponge support inside the middle ear cavity to establish a soft support bed. Step 8: Positioning of the prepared tissue graft medial (underlay) or lateral (overlay) to the remaining membrane tissue. Step 9: Re-positioning the tympanomeatal flap back onto canal walls over the graft edge. Step 10: Packing the external ear canal with specialized absorbable dressing, securing incisions with absorbable sutures, and applying an external mastoid dressing.

Clinical evidence demonstrates multiple clear therapeutic benefits following successful tympanoplasty:

• Infection Control and Ear Stabilization: Surgical closure eliminates middle ear exposure to fluid and pathogens, resolving chronic or recurrent otorrhea in over 85% to 90% of primary cases (AAO-HNS Clinical Guidelines).
• Hearing Restoration: Successful graft uptake reduces or closes the air-bone gap—the discrepancy between inner ear potential and actual mechanical sound conduction—improving functional hearing clarity without external amplification.
• Restoration of Water Exposure Safety: Closure of the eardrum allows patients to resume normal water exposure activities, such as bathing and swimming, without requiring custom water-plug barrier protection.
• Prevention of Progressive Disease: Repairing structural membrane defects halts deep tissue retractions and reduces the future risk of secondary middle ear erosion or cholesteatoma (an skin-lined destructive cyst in the middle ear).

Recovery from tympanoplasty follows a structured clinical timeline focused on graft integration and tissue healing:

• First 24 to 48 Hours: Patients may experience mild incisional discomfort, transient dizziness, and a feeling of ear fullness or muffled sound due to internal surgical packing. Strenuous activity and nose blowing are strictly restricted.
• Days 7 to 14: The initial surgical post-operative visit takes place. Outer ear dressings or visible skin sutures are removed. Internal absorbable gelatin sponge packing remains in place to preserve graft alignment. Dry ear protocols remain absolute.
• Weeks 2 to 6: Microscopic epithelialization proceeds across the graft scaffold. Symptoms of ear popping, mild fluid clicking, or fluctuating pressure are normal as the middle ear mucosal lining recovers. Light non-strenuous daily activities are resumed.
• Weeks 8 to 12: Final anatomical stabilization occurs. An audiometric test (pure-tone audiogram) is performed to measure functional hearing recovery and evaluate residual air-bone gap closure. Water precautions are removed once the clinician confirms full graft epithelialization.

Tympanoplasty is indicated for the treatment of structural and functional pathologies affecting the middle ear assembly. Primary conditions treated include:

• Chronic Tympanic Membrane Perforation: Persistent eardrum tears resulting from severe acute otitis media, chronic middle ear disease, or trauma that fail to heal spontaneously over three months.
• Chronic Suppurative Otitis Media (CSOM): Ongoing inflammation and recurrent purulent discharge through an open eardrum defect.
• Tympanic Membrane Retraction Pockets: Severe collapse or weakening of the eardrum tissue inward toward the middle ear space, which can precede structural destruction or cholesteatoma formation.
• Ossicular Chain Interruption: Discontinuity or fixation of the middle ear bones occurring alongside eardrum perforation, requiring concurrent acoustic reconstruction (ossiculoplasty).

A primary preoperative evaluation includes micro-otoscopy to document perforation geography and a formal diagnostic audiogram to establish baseline pure-tone and speech discrimination scores. Patients actively experiencing purulent drainage receive a course of targeted topical antibiotic ear drops to ensure a non-inflamed, dry operative field. Anticoagulant and antiplatelet medications are reviewed and managed in coordination with the prescribing physician, typically discontinued 5 to 7 days prior to surgery. Patients are instructed to keep the ear entirely dry prior to surgery using cotton saturated with petroleum jelly during bathing. Fasting guidelines for general anesthesia are established, usually requiring no oral intake for 8 hours prior to the planned surgical start time.

Common/Mild Side Effects: Transient surgical site discomfort, mild postoperative vertigo or motion sensitivity, temporary bloody ear canal discharge, altered taste perception (dysgeusia) caused by temporary traction on the chorda tympani nerve, and ear popping or muffled sensation. Uncommon Complications: Primary graft failure or graft displacement leading to persistent or recurrent perforation (5-10% of cases), persistent conductive hearing loss requiring revision intervention, graft lateralization or blunting leading to acoustic dampening, or localized wound infection. Rare/Serious Risks: Direct inner ear trauma resulting in permanent sensorineural hearing loss or profound vertigo, facial nerve injury (CN VII weakness or paralysis) due to operative proximity, or formation of an iatrogenic cholesteatoma beneath the graft placement zone.

The clinical journey for a patient undergoing tympanoplasty begins with a comprehensive outpatient evaluation, including micro-otoscopy and diagnostic audiometry to establish baseline hearing thresholds. Once surgical criteria are met, the patient undergoes preoperative preparation, which includes managing any active middle ear inflammation with topical antibiotic drops. On the day of surgery, the procedure is performed under either local or general anesthesia as an outpatient day surgery. The operating surgeon harvests a donor tissue graft—most commonly temporalis fascia (connective tissue behind the ear) or tragal cartilage—and secures it beneath or over the eardrum remnant under microscopic or endoscopic guidance. The middle ear and ear canal are packed with absorbable gelatin sponges to support graft integration. Patients return home the same day with wound care instructions and strict dry ear precautions. Postoperative follow-up occurs at one to two weeks for dressing inspection, four to six weeks for graft assessment, and eight to twelve weeks for a post-healing audiometric test to evaluate hearing recovery.